Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, ...

A study in Ontario found that schizophrenia cases linked to cannabis use disorder have more than doubled since cannabis ...

The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...

The proportion of incident cases of schizophrenia associated with cannabis use disorder (CUD) almost tripled from the p ...

A new study from Canadian researchers has found that the proportion of new schizophrenia cases associated with cannabis use ...

Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the ...

But that system didn’t work well, as you may experience symptoms of different "types" of schizophrenia at different times. Now, experts describe schizophrenia as a spectrum disorder that ...

How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia.

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...

Psychosis and schizophrenia are related but distinct mental health conditions characterized by distorted thoughts, perceptions, and a sense of reality. Psychosis describes this specific collection ...